Mark Marzinke

26PUBLICATIONS
111CO-AUTHORS
Regenerative medicine (incl. stem cells)Innate immunityPreventative health careImmunogenetics (incl. genetic immunology)Obstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|May 26, 2026
A Narrative Review of Remote Biospecimen Collection Product and Implementation Considerations for Sexual Health Clinical Research.

|Mar 23, 2026
Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

Sean M Hughes, Fernanda L Calienes, Claire N Levy

|Feb 10, 2026
Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.

Betina Durovni, Marcelo Cordeiro-Santos, Solange Cesar Cavalcante

|Nov 03, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083.

Hannah P Moore, Jessica M Fogel, Mark A Marzinke

|Oct 31, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084.

Mark A Marzinke, Brett Hanscom, Daniel Haines

|Oct 20, 2025
Transgender Men and Transmasculine One-on-One and Group-Delivered Empowerment for Targeted HIV Reduction (TOGETHR) Study: Protocol for a Digital Factorial Randomized Controlled Trial.

Sari L Reisner, Ayden I Scheim, S Wilson Cole

Pageof 5

Frequent Collaborators

7 joint publications

Craig W Hendrix

3 joint publications

Mina C Hosseinipour

3 joint publications

Susan H Eshleman

3 joint publications

Jessica M Fogel